Read + Share
Amedeo Smart
Independent Medical Education
Kreis K, Horenkamp-Sonntag D, Schneider U, Zeidler J, et al. Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer. BJU Int 2021 Jul 9. doi: 10.1111/bju.15542.PMID: 34242474
Email
LinkedIn
Facebook
Twitter
Privacy Policy